Childhood cancer survivors 5 times more likely to get cancer again: Study

NewsGuard 100/100 Score

According to a new study, children who survive cancer are at a higher risk of cancer later in life or may die early of other cause. The study included almost 900 young cancer survivors treated at Sydney Children's Hospital, from 1972 to 1999, alongside new cancer cases and early deaths. The risk of cancer was five times higher in childhood cancer survivors, the results showed, compared with the overall NSW population, that these survivors were seven and a half times more likely to die early.

According to lead researcher Dr Lesley Ashton of the Children's Cancer Institute, two-thirds of survivors will develop a related chronic health condition linked to earlier radiation-based treatments. “Good follow up and health care” for these patients is thus important. Dr Lesley Ashton is also the head of the Molecular Epidemiology Program at the Children's Cancer Institute.

In the paper published in the Medical Journal of Australia, Dr Ashton wrote, “Our results highlight that it is important for cancer survivors to be aware of the risk factors for complications of treatment and second cancers, and maintain good follow-up health care…we continue to look at how current therapies can be further improved.” Dr. Ashton explained that these survivors may develop new tumors - particularly thyroid, breast, bone or brain cancers - linked to earlier radiation-based treatments. He said the link may be in genes adding, “Previous research has shown there's an underlying genetic basis for the way patients respond to cancer treatments…This same genetic variation is likely to contribute to these long-term effects of cancer therapy. This is an area we are interested in pursuing…If we can map the genetic factors, we can develop more individualized cancer treatments that do not result in long-term health complications.”

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). Childhood cancer survivors 5 times more likely to get cancer again: Study. News-Medical. Retrieved on April 20, 2024 from https://www.news-medical.net/news/20100905/Childhood-cancer-survivors-5-times-more-likely-to-get-cancer-again-Study.aspx.

  • MLA

    Mandal, Ananya. "Childhood cancer survivors 5 times more likely to get cancer again: Study". News-Medical. 20 April 2024. <https://www.news-medical.net/news/20100905/Childhood-cancer-survivors-5-times-more-likely-to-get-cancer-again-Study.aspx>.

  • Chicago

    Mandal, Ananya. "Childhood cancer survivors 5 times more likely to get cancer again: Study". News-Medical. https://www.news-medical.net/news/20100905/Childhood-cancer-survivors-5-times-more-likely-to-get-cancer-again-Study.aspx. (accessed April 20, 2024).

  • Harvard

    Mandal, Ananya. 2018. Childhood cancer survivors 5 times more likely to get cancer again: Study. News-Medical, viewed 20 April 2024, https://www.news-medical.net/news/20100905/Childhood-cancer-survivors-5-times-more-likely-to-get-cancer-again-Study.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New microfluidic device improves the separation of tumor cells and clusters from malignant effusions